Follow-up after acute thrombotic events following COVID-19 infection

Christopher M Faries1, Ajit Rao1, Nicole Ilonzo1

  • 1Department of Surgery, Division of Vascular Surgery, New York, NY.

Insights

COVID-19 infection causes blood clots, leading to high mortality and complication rates in patients experiencing arterial thrombotic events. Follow-up revealed poor outcomes and low patency rates for treated patients.

Area of Science:

  • Vascular Surgery
  • Infectious Diseases
  • Cardiology

Background:

  • COVID-19 infection is associated with a hypercoagulable state.
  • Thrombotic events are a significant complication in patients with COVID-19.

Purpose of the Study:

  • To report the 3- and 6-month follow-up of patients with acute arterial thrombotic events secondary to COVID-19 infection.
  • To evaluate outcomes, including mortality, patency rates, and limb salvage, in this patient cohort.

Main Methods:

  • Prospective data collection of vascular surgery consultations for patients with COVID-19 presenting with arterial thrombotic events.
  • Analysis of treatment strategies including open surgical intervention, endovascular intervention, and anticoagulation.
  • Assessment of 3- and 6-month follow-up data for mortality, primary patency, and limb salvage rates.

Main Results:

  • Twenty-seven patients experienced acute arterial thrombotic events.
  • At 6 months, 48.0% of patients were deceased, with a cumulative primary patency rate of 61.9%.
  • The limb-salvage rate at 6 months was 89.2%.

Conclusions:

  • Patients with COVID-19 experiencing thrombotic events face high mortality and complication rates.
  • Intervention outcomes were characterized by relatively low patency rates.
  • Vigilant monitoring and management strategies are crucial for this high-risk patient group.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
60
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
48
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
68
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
53
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
31
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
74